Savient Pharmaceuticals (SVNT)

0.555 -0.01  -0.89%  May 20, 8:00PM
Add to Watchlists Create an Alert

Savient Pharmaceuticals Cash from Investing Quarterly:

2.476M for Dec. 31, 2012
View Full Chart

Savient Pharmaceuticals Cash from Investing Quarterly Chart

    Savient Pharmaceuticals Historical Cash from Investing Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 2.476M
    Sept. 30, 2012 0.424M
    June 30, 2012 -1.746M
    March 31, 2012 7.063M
    Dec. 31, 2011 -9.311M
    Sept. 30, 2011 -6.311M
    June 30, 2011 -12.21M
    March 31, 2011 -9.508M
    Dec. 31, 2010 -5.525M
    Sept. 30, 2010 5.109M
    June 30, 2010 -3.746M
    March 31, 2010 -16.14M
    Dec. 31, 2009 0.002M
    Sept. 30, 2009 2.565M
    June 30, 2009 0.379M
    March 31, 2009 1.138M
    Dec. 31, 2008 1.691M
    Sept. 30, 2008 2.739M
    June 30, 2008 2.331M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
       
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro
    Sept. 30, 2000 Go Pro

    About Cash From Investing

    An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
    Learn More

    Get data for

    SVNT Cash from Investing Quarterly Benchmarks

    Companies
    Corcept Therapeutics -0.058M
    BioTime -0.1959M
    Omeros Corporation 8.332M

    SVNT Cash from Investing Quarterly Rankings

    Overall 93rd percentile
    520 of 8002
    Sector 90th percentile
    62 of 650 in Healthcare
    Industry 85th percentile
    35 of 237 in Biotechnology

    SVNT Cash from Investing Quarterly Range, Past 5 Years

    Minimum -16.14M Mar 2010
    Maximum 7.063M Mar 2012
    Average -2.031M